-
Signature
-
/s/ Mark Jacobson
-
Issuer symbol
-
AXSM
-
Transactions as of
-
27 May 2025
-
Net transactions value
-
-$3,969,482
-
Form type
-
4
-
Filing time
-
28 May 2025, 21:52:55 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Jacobson Mark L. |
Chief Operating Officer |
C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK |
/s/ Mark Jacobson |
28 May 2025 |
0001805812 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AXSM |
Common Stock |
Options Exercise |
$133,754 |
+20,673 |
+357% |
$6.47 |
26,456 |
27 May 2025 |
Direct |
F1, F2 |
| transaction |
AXSM |
Common Stock |
Sale |
$2,163,636 |
-20,673 |
-78% |
$104.66 |
5,783 |
27 May 2025 |
Direct |
F2, F3, F4 |
| transaction |
AXSM |
Common Stock |
Options Exercise |
$129,400 |
+20,000 |
+346% |
$6.47 |
25,783 |
28 May 2025 |
Direct |
F1, F2 |
| transaction |
AXSM |
Common Stock |
Sale |
$2,069,000 |
-20,000 |
-78% |
$103.45 |
5,783 |
28 May 2025 |
Direct |
F2, F3, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AXSM |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-20,673 |
-100% |
$0.000000 |
0 |
27 May 2025 |
Common Stock |
20,673 |
$6.47 |
Direct |
F1, F2 |
| transaction |
AXSM |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-20,000 |
-100% |
$0.000000 |
0 |
28 May 2025 |
Common Stock |
20,000 |
$6.47 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: